StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$40.48−0.52 (-1.26%)

Close on Nov 13, 2026Market cap $3.92BP/E –Yield –

Xenon Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Xenon Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2025 was -4612.1%. For fiscal 2025 it was -4612.1%, against -1328.9% the year before. The highest annual figure on record is 45.9% in fiscal 2014.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-4612.1%−3283.2
FY2022Dec 31, 2022-1328.9%−901.1
FY2021Dec 31, 2021-427.8%−338.2
FY2020Dec 31, 2020-89.7%+519.4
FY2019Dec 31, 2019-609.1%+9263.6
FY2017Dec 31, 2017-9872.7%−8597.2
FY2016Dec 31, 2016-1275.5%−1174.4
FY2015Dec 31, 2015-101.1%−147.0
FY2014Dec 31, 201445.9%+1.9
FY2013Dec 31, 201344.0%+74.0
FY2012Dec 31, 2012-30.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 2025-867.3%−183.2
Q3 FY2022Sep 30, 2022-28143.9%−27953.8
Q2 FY2022Jun 30, 2022-5813.1%−4816.3
Q1 FY2022Mar 31, 2022-224.4%+137.3
Q4 FY2021Dec 31, 2021-684.1%−444.8
Q3 FY2021Sep 30, 2021-190.1%−55.0
Q2 FY2021Jun 30, 2021-996.8%−995.5
Q1 FY2021Mar 31, 2021-361.7%−256.0
Q4 FY2020Dec 31, 2020-239.3%+102.4
Q3 FY2020Sep 30, 2020-135.1%+118.3
Q2 FY2020Jun 30, 2020-1.3%+50404.9
Q1 FY2020Mar 31, 2020-105.7%+2826.8
Q4 FY2019Dec 31, 2019-341.7%+48858.3
Q3 FY2019Sep 30, 2019-253.5%+46727.8
Q4 FY2017Dec 31, 2017-50406.3%−48809.4
Q3 FY2017Sep 30, 2017-2932.6%–
Q2 FY2017Jun 30, 2017-49200.0%–
Q1 FY2017Mar 31, 2017-46981.3%–
Q4 FY2016Dec 31, 2016-1596.8%–

More Xenon Pharmaceuticals figures

See a number that looks wrong?